Target Name: LINC01254
NCBI ID: G101927350
Other Name(s): Long intergenic non-protein coding RNA 1254 | long intergenic non-protein coding RNA 1254

LINC01254: A Potential Drug Target and Biomarker

LINC01254 is a non-protein coding RNA (ncRNA) molecule that has been identified as a potential drug target and biomarker. It is located within the intron of the gene PMZ223317, which encodes a protein known as PMZ223318. PMZ223318 is a protein that is involved in the intracellular signaling pathway known as the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

The NF-kappa pathway is a complex signaling pathway that is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival. It is a key factor in the development and progression of many diseases, including cancer, and is a potential drug target for the development of new therapies.

LINC01254 is a non-protein coding RNA molecule that is located within the intron of the gene PMZ223317, which encodes a protein known as PMZ223318. PMZ223318 is a protein that is involved in the intracellular signaling pathway known as the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

The NF-kappa pathway is a complex signaling pathway that is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival. It is a key factor in the development and progression of many diseases, including cancer, and is a potential drug target for the development of new therapies.

LINC01254 is a potential drug target because it is involved in the regulation of the NF-kappa pathway. This pathway is a key factor in the development and progression of many diseases, including cancer, and targeting LINC01254 could potentially lead to the development of new therapies that can treat these diseases.

LINC01254 is also a potential biomarker for the diagnosis and prognosis of many diseases, including cancer. The NF-kappa pathway is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases. By targeting LINC01254, researchers could potentially develop new diagnostic tests and biomarkers for the diagnosis and prognosis of these diseases.

The Identification of LINC01254 as a Potential Drug Target

The identification of LINC01254 as a potential drug target was based on its location within the intron of the gene PMZ223317, which encodes a protein known as PMZ223318. PMZ223318 is a protein that is involved in the intracellular signaling pathway known as the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

LINC01254 is a non-protein coding RNA molecule that is expressed in many different tissues and cells. It is located within the intron of the gene PMZ223317, which encodes a protein known as PMZ223318. PMZ223318 is a protein that is involved in the intracellular signaling pathway known as the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

The identification of LINC01254 as a potential drug target was based on its location within the intron of the gene PMZ223317, which encodes a protein known as PMZ223318. PMZ223318 is a protein that is involved in the intracellular signaling pathway known as the TGF-

Protein Name: Long Intergenic Non-protein Coding RNA 1254

More Common Targets

LINC01255 | LINC01257 | LINC01258 | LINC01260 | LINC01262 | LINC01266 | LINC01267 | LINC01269 | LINC01270 | LINC01271 | LINC01276 | LINC01277 | LINC01278 | LINC01280 | LINC01281 | LINC01287 | LINC01288 | LINC01289 | LINC01291 | LINC01293 | LINC01299 | LINC01300 | LINC01303 | LINC01307 | LINC01310 | LINC01311 | LINC01312 | LINC01315 | LINC01317 | LINC01320 | LINC01322 | LINC01331 | LINC01337 | LINC01338 | LINC01339 | LINC01341 | LINC01342 | LINC01343 | LINC01346 | LINC01347 | LINC01348 | LINC01352 | LINC01354 | LINC01355 | LINC01356 | LINC01358 | LINC01359 | LINC01360 | LINC01362 | LINC01363 | LINC01364 | LINC01366 | LINC01372 | LINC01374 | LINC01378 | LINC01387 | LINC01389 | LINC01392 | LINC01393 | LINC01394 | LINC01395 | LINC01397 | LINC01399 | LINC01405 | LINC01410 | LINC01411 | LINC01412 | LINC01413 | LINC01414 | LINC01415 | LINC01419 | LINC01423 | LINC01425 | LINC01426 | LINC01427 | LINC01428 | LINC01429 | LINC01430 | LINC01432 | LINC01433 | LINC01435 | LINC01436 | LINC01442 | LINC01443 | LINC01446 | LINC01447 | LINC01450 | LINC01451 | LINC01456 | LINC01465 | LINC01467 | LINC01470 | LINC01471 | LINC01474 | LINC01475 | LINC01476 | LINC01477 | LINC01478 | LINC01479 | LINC01480